Methyl 4-[5-(1-propan-2-yl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl)-1,2,4-oxadiazol-3-yl]piperidine-1-carboxylate
C18H26N6O3 — CID 155066846
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 4-[5-(1-propan-2-yl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl)-1,2,4-oxadiazol-3-yl]piperidine-1-carboxylate
Methyl 4-[5-(1-propan-2-yl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl)-1,2,4-oxadiazol-3-yl]piperidine-1-carboxylate (PubChem CID 155066846) has the molecular formula C18H26N6O3 and a molecular weight of 374.45 g/mol. Its IUPAC name is methyl 4-[5-(1-propan-2-yl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl)-1,2,4-oxadiazol-3-yl]piperidine-1-carboxylate.
Molecular Properties
| Compound Name | Methyl 4-[5-(1-propan-2-yl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl)-1,2,4-oxadiazol-3-yl]piperidine-1-carboxylate |
|---|---|
| PubChem CID | 155066846 |
| Molecular Formula | C18H26N6O3 |
| Molecular Weight | 374.45 g/mol |
| Exact Mass | 374.21 |
| IUPAC Name | methyl 4-[5-(1-propan-2-yl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl)-1,2,4-oxadiazol-3-yl]piperidine-1-carboxylate |
| SMILES | COC(=O)N1CCC(c2noc(N3CCc4cnn(C(C)C)c4C3)n2)CC1 |
| InChI | InChI=1S/C18H26N6O3/c1-12(2)24-15-11-23(9-6-14(15)10-19-24)17-20-16(21-27-17)13-4-7-22(8-5-13)18(25)26-3/h10,12-13H,4-9,11H2,1-3H3 |
| InChIKey | GYHJQNOTSOBVSI-UHFFFAOYSA-N |
| XLogP | 2.36 |
| TPSA | 89.52 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 374.45 |
| LogP ≤ 5 | 2.36 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155066846 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.